Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Angiogenesis inhibitors derived from thalidomide.

Tomomi Noguchi1, Haruka Fujimoto, Hiroko Sano

  • 1Institute of Molecular and Cellular Biosciences, The University of Tokyo, 1-1-1 Yayoi, Bunkyo-ku, Tokyo 113-0032, Japan.

Bioorganic & Medicinal Chemistry Letters
|September 27, 2005
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Synthesis of DNA-Encoded Libraries by Tryptophan-Selective Bioconjugation.

Organic letters·2026
Same author

CYP3A5 polymorphism affects the disposition of tacrolimus and its metabolite in systemic circulation and peripheral tissues of mice introduced with the CYP3A5 gene.

Drug metabolism and disposition: the biological fate of chemicals·2026
Same author

Comparative analyses of transcriptionally regulated downstream genes between arbuscular mycorrhizal and ectomycorrhizal symbioses in the single host plant Eucalyptus grandis.

Mycorrhiza·2026
Same author

[Proximal Stepwise Anastomosis in Stanford Type A Acute Aortic Dissection Surgery].

Kyobu geka. The Japanese journal of thoracic surgery·2026
Same author

GRIm Score Predicts Curative Conversion Surgery in Unresectable Gastric Cancer.

Cancer diagnosis & prognosis·2026
Same author

On-DNA Platform Molecules Based on a Diazide Scaffold II: A Compact Diazide Platform Designed for Small-Molecule Drug Discovery.

International journal of molecular sciences·2026
Same journal

Solid-phase synthesis and antimicrobial activities of lipid-neomycin conjugates.

Bioorganic & medicinal chemistry letters·2026
Same journal

Discovery of a potent sGC stimulator with once-daily dosing potential for the treatment of hypertension.

Bioorganic & medicinal chemistry letters·2026
Same journal

OracleScreen-LILRB4 (HTS-Oracle v3): machine learning-guided discovery of myeloid immune checkpoint binders validated in patient-derived cells.

Bioorganic & medicinal chemistry letters·2026
Same journal

Rational design and N-terminal acylation of a lactam-cyclized 11-residue antimicrobial peptide for improved antibacterial potency.

Bioorganic & medicinal chemistry letters·2026
Same journal

Rational design, synthesis, and biological evaluation of chalcone hybrids including benzoylpiperazin (phenylacetylpiperazin)-thiophene as anti- Alzheimer's agents.

Bioorganic & medicinal chemistry letters·2026
Same journal

New aminopiperidine-azoles as antifungal agents against Candida albicans with mechanistic insights into the cAMP-PKA pathway.

Bioorganic & medicinal chemistry letters·2026
See all related articles

5-Hydroxy-2-(2,6-diisopropylphenyl)-1H-isoindole-1,3-dione (5HPP-33) exhibits potent anti-angiogenic activity. This compound, derived from thalidomide research, shows promise in inhibiting blood vessel formation.

Area of Science:

  • Pharmacology
  • Biochemistry
  • Cell Biology

Background:

  • Thalidomide derivatives are investigated for therapeutic potential.
  • Structural modifications of thalidomide have yielded compounds with varied biological activities.
  • Angiogenesis plays a critical role in various physiological and pathological processes.

Purpose of the Study:

  • To evaluate the anti-angiogenic potential of 5-Hydroxy-2-(2,6-diisopropylphenyl)-1H-isoindole-1,3-dione (5HPP-33).
  • To compare the activity of 5HPP-33 with thalidomide and its metabolite, 5-hydroxythalidomide (5-HT).
  • To explore the structure-activity relationship of thalidomide analogs in angiogenesis.

Main Methods:

  • Human umbilical vein endothelial cell (HUVEC) assay was employed.
  • In vitro assessment of anti-angiogenic properties.

Related Experiment Videos

  • Comparative analysis of compound activities.

    • Main Results:

    • 5-Hydroxy-2-(2,6-diisopropylphenyl)-1H-isoindole-1,3-dione (5HPP-33) demonstrated potent anti-angiogenic activity.
    • Thalidomide (1) and 5-hydroxythalidomide (5-HT: 2) exhibited weak to moderate activity.
    • Immunomodulatory derivatives of thalidomide (IMiDs: 3 and 5) also showed varying degrees of anti-angiogenic effects.

    Conclusions:

    • 5HPP-33 is a potent inhibitor of angiogenesis.
    • The structural features of 5HPP-33 contribute to its enhanced anti-angiogenic efficacy compared to thalidomide and its metabolite.
    • Further investigation into 5HPP-33 and related compounds is warranted for therapeutic applications in angiogenesis-dependent diseases.